
Anti-Obesity Drug Could Cost Just $3 Per Month, Study Finds
What if one of the world’s most talked-about weight-loss drugs suddenly became affordable for almost everyone? That possibility may be closer than many think. Researchers say semaglutide—the active ingredient behind blockbuster treatments like Ozempic and Wegovy made by Novo Nordisk—could cost as little as $3 per month to manufacture. Once patents expire in several countries










